| Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure. | |
| | |
MedLine Citation:
|
PMID: 12468058 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Chronic heart failure (CHF) is characterized by the activation of neurohormones and cytokines. Strenuous exercise causes activation of both systems but the effect of acute bouts of exercise on cytokines is not known in patients with CHF. This study determined whether maximal exercise induces activation of cytokines in CHF. Plasma interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, epinephrine, norepinephrine, and atrial and brain natriuretic peptides (ANP and BNP) were determined before and after symptom-limited cardiopulmonary exercise testing in 80 patients with CHF (LVEF=38+/-1%, peak VO(2)=18.8+/-0.5 ml/min/kg) and age-matched 33 controls. Resting IL-6 (Controls vs. CHF: 1.3+/-0.2 vs. 2.5+/-0.3 pg/ml, P<0.001) and TNF-alpha (2.7+/-0.2 vs. 3.8+/-0.2 pg/ml, P<0.01) were elevated in CHF. LogIL-6 and logTNF-alpha were positively correlated (r=0.34 and r=0.35, respectively) with logplasma norepinephrine, and were negatively correlated (r=-0.39 and r=-0.32, respectively) with peak VO(2). Maximal exercise increased IL-6 and TNF-alpha both in controls and CHF (all P<0.01). Changes in IL-6 (DeltaIL-6) correlated with Deltaepinephrine (r=0.63, P<0.0001) and Deltanorepinephrine (r=0.57, P=0.0006) in controls, but not in CHF. DeltaTNF-alpha correlated with DeltaANP (r=0.28, P=0.01) only in CHF. In summary, cytokine activation at rest was associated with high plasma norepinephrine and exercise intolerance. Maximal exercise caused increases in IL-6 and TNF-alpha concentrations. Sympathetic activation seems to be important for the IL-6 increase during exercise in controls. In CHF, changes in ANP during exercise were associated with the exercise-induced increase in TNF-alpha, but still unknown mechanisms are involved for the cytokine activation during exercise. |
| | |
Authors:
|
Toru Kinugawa; Masahiko Kato; Kazuhide Ogino; Shuichi Osaki; Yoko Tomikura; Osamu Igawa; Ichiro Hisatome; Chiaki Shigemasa |
Related Documents
:
|
16159968 - Chronic heart failure, chronotropic incompetence, and the effects of beta blockade. 2125668 - The role of oxygen extraction in peripheral tissues in exercise capacity in chronic hea... 15704528 - Heart rate response to graded exercise correlates with aerobic and ventilatory capacity... 15894768 - Allopurinol reduces b-type natriuretic peptide concentrations and haemoglobin but does ... 8909698 - Fluid electrolyte changes in trained subjects after water loading and during restrictio... 17894138 - Management of foreign bodies in the skin. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International journal of cardiology Volume: 87 ISSN: 0167-5273 ISO Abbreviation: Int. J. Cardiol. Publication Date: 2003 Jan |
Date Detail:
|
Created Date: 2002-12-06 Completed Date: 2003-04-22 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: Ireland |
Other Details:
|
Languages: eng Pagination: 83-90 Citation Subset: IM |
Affiliation:
|
Division of Cardiology, First Department of Internal Medicine, Tottori University Faculty of Medicine, Yonago, Japan. kinugawa@grape.med.tottori-u.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Atrial Natriuretic Factor
/
blood Case-Control Studies Chronic Disease Epinephrine / blood Exercise Test* Female Heart Failure / blood* Humans Interleukin-6 / blood* Linear Models Male Middle Aged Natriuretic Peptide, Brain / blood Norepinephrine / blood Statistics, Nonparametric Tumor Necrosis Factor-alpha / metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Interleukin-6; 0/Tumor Necrosis Factor-alpha; 114471-18-0/Natriuretic Peptide, Brain; 51-41-2/Norepinephrine; 51-43-4/Epinephrine; 85637-73-6/Atrial Natriuretic Factor |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prognostic significance of heart rate variability in dilated cardiomyopathy.
Next Document: Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role?